Investor Login

This area is for use by Limited Partners of the funds managed by MML Capital Partners only.

MML Capital Partners uses PEARonline, a secure, web-based service for investor reporting. PEARonline allows investors to access reports, accounts and other fund information 24 hours a day, 365 days a year and additionally gives investors access to all other funds that report through the service from a single site with a single username and password.

To log in to PEARonline, please follow this link. If you would like to gain access to information on our funds through PEARonline, please contact Alison Jackson at ajackson@mmlcapital.com

If you have any questions about PEARonline or need any support using this service, please contact PEARonline on +1 408 740-5226 or email support@pearonline.com

See how we have grown

Press Releases

Apr 2016
IQARUS spreads its wings with ExMed acquisition

MML backed IQARUS (www.iqarus.com) has accelerated its global growth strategy through the acquisition of Exmed, a leader in medical solutions in some of the most remote and challenging operating environments worldwide.

Exmed’s services include remote medical support, equipment and clinical education. These services are provided to prominent international government and humanitarian agencies as well as global energy companies and media organisations.

Tim Mitchell, CEO of IQARUS comments: “Our ambition since launching IQARUS has been to rapidly grow into a global provider of health solutions in the world’s difficult and remote environments. The acquisition of Exmed is a major catalyst for our international expansion. The team are amongst the most highly regarded providers of healthcare in challenging locations. The calibre of international humanitarian and government customers that they serve and the level of trust that they command in the market is a testament to their skill and professionalism. We are proud that they will be joining IQARUS and will play a key role in our growth going forward.”

Robert Devonshire, MML, comments:  “This acquisition is a major step in IQARUS’s global ambitions. The team have made impressive progress in executing their international strategy and we look forward to continuing to support it.”

MML invested into IQARUS in October 2015 from its recently raised €438m Fund VI.

IQARUS was acquired as a platform from which to develop an international provider of remote healthcare solutions. Exmed is the second acquisition that MML has supported alongside significant investment in new IT for technology enabled medical solutions.

Case Study

FrontierMEDEX

undefined

By using the mmlcapital.com website you agree to our use of cookies as described in our cookie policy.

Learn More